Pivotal Trial of Enfortumab Vedotin in Urothelial Carcinoma After Platinum and Anti- Programmed Death 1/Programmed Death Ligand 1 Therapy - Rosenberg, JE; O'Donnell, PH; Balar, AV (J Clin Oncol, 2019)
et al.